跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
英飞凡 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Durvalumab Injection
Approved
生物制品
Durvalumab Injection
ASTRAZENECA UK LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 23, 2024
Approval ID
8cImWj0nGqD
Company
ASTRAZENECA UK LIMITED
Type
生物制品
Approval Details
Approval Id
8cImWj0nGqD
Approval Number
国药准字SJ20190038
Generic Name
度伐利尤单抗注射液
Generic Name En
Durvalumab Injection
Trade Name
英飞凡
Drug Type
生物制品
Dosage Form
注射剂
Strength
500mg/10mL
Reg Date
2024-05-23
Expired Date
2029-05-22
Company Name
ASTRAZENECA UK LIMITED
Production Company Name
Catalent Indiana, LLC
Company Detail Path
/organization/astrazeneca-uk-limited
Production Company Detail Path
/organization/catalent-indiana-llc-bloomington-indiana-united-states
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 23, 2024
Approval ID
8cImWj0nGqD
Type
生物制品
Back to NMPA Approvals